1-2 of 2
Katayoun Ayasoufi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A056: TNFR2 is a novel marker of exhaustion and TNFR2 blockade improves subcutaneous tumor control

Free
Alexandra Hoyt-Miggelbrink, Jessica Waibl Polania, Aditya Mohan, Luke Wachsmuth, Selena Lorrey, Emily Lerner, Daniel Wilkinson, Andrew Hardigan, Kelly Hotchkiss, Saskia Hemmers, Sarah Cook Quackenbush, Katayoun Ayasoufi, Peter Fecci
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): A056.
https://doi.org/10.1158/2326-6074.TUMIMM24-A056
Published: 18 October 2024
View article titled, Abstract A056: TNFR2 is a novel marker of exhaustion and TNFR2 blockade improves subcutaneous tumor control
Journal Articles

Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression

Available to Purchase
Zachariah P. Tritz, Katayoun Ayasoufi, Delaney M. Wolf, Carley A. Owens, Courtney S. Malo, Benjamin T. Himes, Cori E. Fain, Emma N. Goddery, Lila T. Yokanovich, Fang Jin, Michael J. Hansen, Ian F. Parney, Chensu Wang, Kelly D. Moynihan, Darrell J. Irvine, K. Dane Wittrup, Rosa M. Diaz Marcano, Richard G. Vile, Aaron J. Johnson
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (6): 763–776.
https://doi.org/10.1158/2326-6066.CIR-22-0570
Published: 02 June 2023
View article titled, Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
Open the PDF for Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression in another window
Includes: Supplementary data